Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Stephen MuhiDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-3161-8199
Isabelle J H FooDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Lukasz KedzierskiDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Jessica L PorterDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Hayley A McQuiltenDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Brian HowdenDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Katherine Kedzierska *Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0001-6141-335X
Andrew H Buultjens *Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-5984-1328
Brendon Y Chua *Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
Timothy P Stinear *Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-0150-123X
Funding
National Health and Medical Research Council GNT1191368National Health and Medical Research Council GNT1194325
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A refined low-dose murine model of · full record | OpenQuestion